Matthew J. Cortese

Oncology

3199 Highland Ave
Cincinnati, OH 45219

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.

NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 13, 2026

Treatment of older adults with peripheral T cell lymphoma (PTCL) amidst a changing therapeutic landscape: a 20-year single institution experience.

Treatment of older adults with peripheral T cell lymphoma (PTCL) amidst a changing therapeutic landscape: a 20-year single institution experience.

Journal: Leukemia & lymphoma

Published: December 05, 2025

Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.

Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patients.

Journal: Leukemia & lymphoma

Published: November 13, 2025

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART.

Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART.

Journal: Cancers

Published: May 28, 2025

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium.

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium.

Journal: Blood advances

Published: May 09, 2025

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium.

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium.

Journal: Blood advances

Published: April 24, 2025

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 16, 2024

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.

Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.

Journal: Blood advances

Published: January 04, 2024

Impact of active surveillance at time of diagnosis on overall survival in nodular lymphocyte-predominant Hodgkin lymphoma: A National Cancer Database study.

Impact of active surveillance at time of diagnosis on overall survival in nodular lymphocyte-predominant Hodgkin lymphoma: A National Cancer Database study.

Journal: Leukemia research

Published: August 16, 2023

A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.

A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.

Journal: Leukemia & lymphoma

Published: November 02, 2022

A "CRISPR" non-viral manufacturing approach for CAR T cell therapies.

A "CRISPR" non-viral manufacturing approach for CAR T cell therapies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 30, 2022

Emerging Targets and Cellular Therapy for Relapsed Refractory Multiple Myeloma: A Systematic Review.

Emerging Targets and Cellular Therapy for Relapsed Refractory Multiple Myeloma: A Systematic Review.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 22, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026